UBS price target lowered to CHF29 from CHF31.50 at RBC Capital

Published 19/06/2025, 08:06
UBS price target lowered to CHF29 from CHF31.50 at RBC Capital

RBC Capital lowered its price target on UBS Group AG (NYSE:UBS) to CHF29.00 from CHF31.50 on Thursday, while maintaining an Outperform rating on the Swiss banking giant’s stock. According to InvestingPro data, UBS currently trades at $30.77, with analysts maintaining a consensus buy recommendation.

The adjustment comes in response to Switzerland’s current "Too Big To Fail" (TBTF) regulatory proposal, which RBC Capital describes as appearing to represent a "worst case" scenario for the bank.

RBC Capital believes UBS could absorb the regulatory changes without further cuts to shareholder distributions, citing the proposal’s longer implementation period as a mitigating factor.

The firm incorporated what it calls a "harsher outcome" on deferred tax assets and software in its valuation model, leading to the reduced price target, though the new target remains above UBS’s current share price.

Despite near-term regulatory pressures, RBC Capital sees "potential for a more favourable outcome and possibly capital optimisation benefits" for UBS, while noting it will "take time to have full visibility" on the situation.

In other recent news, UBS Group AG reported significant developments concerning its capital requirements and analyst ratings. UBS has been actively contesting new regulatory proposals by the Swiss Federal Council that would increase its capital requirements, potentially requiring an additional $42 billion in Common Equity Tier 1 (CET1) capital. Despite this, UBS plans to maintain its financial targets and continue with its capital return plans, including a dividend increase and share buybacks in 2025. In the realm of analyst ratings, Jefferies upgraded UBS’s stock from Hold to Buy, citing expected clarity in the bank’s capital situation and a positive earnings outlook. They set a new price target of CHF37.00, highlighting optimism about UBS’s earnings trajectory and return on tangible equity. Conversely, Morgan Stanley (NYSE:MS) downgraded UBS from Equalweight to Underweight, expressing concerns about capital constraints and reducing its price target to CHF26.00. Meanwhile, Citi maintained a Neutral rating, acknowledging the extended transition period for UBS to meet new capital requirements. These developments reflect ongoing discussions and adjustments in UBS’s strategic financial planning amid evolving regulatory landscapes.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.